FDA
-
-
-
-
-
-
-
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
-
-
-
-
-
-
-
Antares Pharma (ATRS) Reports FDA Acceptance of NDA Resubmission for TLANDO
-
-
-
-
-
-
-
Antares Pharma Announces Divestiture of Otrexup®
-
-
-
-
-
-
-
Antares Pharma to Report Third Quarter 2021 Financial and Operating Results
-
-
-
-
-
-
-
Antares Pharma (ATRS) Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis Rescue
-
-
-
-
-
-
-
Antares Pharma Announces Submission of IND Application for ATRS-1902 for Adrenal Crisis Rescue
-
-
-
-
-
-
-
Antares Pharma to Report First Quarter 2021 Financial and Operating Results
-
251,365 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All